BackgroundCheck.run
Search For

John E Finn, 85619 Susana Ave, Redondo Beach, CA 90277

Known as:
John Edward Finn Sherry E Finn Sherry M Finn Sherry Marie Finn Sherry John Finn John T Finn Sherri Finn
Related to:
Kailie C Kent 20

John Finn Phones & Addresses

619 Susana Ave, Redondo Beach, CA 90277    310-5432469   

Denton, TX   

La Jolla, CA   

Los Angeles, CA   

Get Report
Control this profile

Mentions for John E Finn

Career records & work history

Lawyers & Attorneys

John Finn Photo 1

John Finn - Lawyer

ISLN:
1000809284
Admitted:
2017
John Finn Photo 2

John Finn - Lawyer

Office:
Stettner Miller, P.C.
Specialties:
Management Employment Law, Corporate Law, Bankruptcy, Business Law, Insurance Law, Construction Law, Litigation
ISLN:
907423391
Admitted:
1976
University:
Lehigh University, B.A., 1973
Law School:
University of Denver, J.D., 1975

Medicine Doctors

John Finn Photo 3

Dr. John P Finn, Los Angeles CA - MD (Doctor of Medicine)

Specialties:
Diagnostic Radiology
Address:
Diagnostic Radiologists
757 Westwood Plz, Los Angeles, CA 90095
310-3016800 (Phone)
UCLA Medical Center MRI Resrch
300 Medical Plaza Way, Los Angeles, CA 90095
310-2063098 (Phone)
Certifications:
Diagnostic Radiology, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Diagnostic Radiologists
757 Westwood Plz, Los Angeles, CA 90095
UCLA Medical Center MRI Resrch
300 Medical Plaza Way, Los Angeles, CA 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plaza, Los Angeles, CA 90095
Education:
Medical School
Royal College Of Surgeons In Ireland, National University Of Ireland, School Of Medicine
Graduated: 1978
Medical School
Royal Postgrad Med School
Graduated: 1986
Medical School
University Hospital
Graduated: 1983
Medical School
National Hospital Neur
Graduated: 1988
John Finn Photo 4

John P Finn, Torrance CA

Specialties:
Physical Therapy
Orthopedic Physical Therapy
Address:
23456 Hawthorne Blvd Suite 200, Torrance, CA 90505
310-7914040 (Phone)
Languages:
English

John C. Finn

Specialties:
Facial Plastic Surgery
Work:
Finn Facial Plastic
1390 Environ Way, Chapel Hill, NC 27517
919-9339522 (phone) 919-9339453 (fax)
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 1989
Procedures:
Cleft Lip or Nasal Deformity Repair, Rhinoplasty, Skull/Facial Bone Fractures and Dislocations
Conditions:
Chronic Sinusitis, Deviated Nasal Septum
Languages:
English
Description:
Dr. Finn graduated from the Case Western Reserve University School of Medicine in 1989. He works in Chapel Hill, NC and specializes in Facial Plastic Surgery. Dr. Finn is affiliated with North Carolina Specialty Hospital.

John G. Finn

Specialties:
Cardiovascular Disease
Work:
Bay Area Heart Center
5398 Park St N, Saint Petersburg, FL 33709
727-5441441 (phone) 727-5458263 (fax)
Site
Bay Area Heart Center
4805 49 St N, Saint Petersburg, FL 33709
727-5266624 (phone) 727-5458263 (fax)
Site
Education:
Medical School
University of Vermont COM
Graduated: 1973
Procedures:
Cardiac Catheterization, Cardiac Stress Test, Continuous EKG, Echocardiogram, Electrocardiogram (EKG or ECG), Pacemaker and Defibrillator Procedures
Conditions:
Cardiac Arrhythmia, Conduction Disorders, Paroxysmal Supreventricular Tachycardia (PSVT), Valvular Heart Disease, Abdominal Aortic Aneurysm, Acute Myocardial Infarction (AMI), Anemia, Angina Pectoris, Aortic Regurgitation, Aortic Stenosis, Aortic Valvular Disease, Atherosclerosis, Atrial Fibrillation and Atrial Flutter, Cardiomyopathy, Chronic Renal Disease, Congenital Anomalies of the Heart, Dehydration, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Endocarditis, Gastrointestinal Hemorrhage, Heart Failure, Hypertension (HTN), Hypothyroidism, Ischemic Heart Disease, Ischemic Stroke, Mitral Valvular Disease, Overweight and Obesity, Pulmonary Embolism, Septicemia, Skin and Subcutaneous Infections, Substance Abuse and/or Dependency, Transient Cerebral Ischemia, Venous Embolism and Thrombosis
Languages:
English, Polish, Spanish
Description:
Dr. Finn graduated from the University of Vermont COM in 1973. He works in Saint Petersburg, FL and 1 other location and specializes in Cardiovascular Disease. Dr. Finn is affiliated with Bayfront Health St Petersburg, Largo Medical Center Indian Rocks, Northside Hospital and St Anthonys Hospital.

John P. Finn

Specialties:
Diagnostic Radiology, Cardiothoracic Radiology
Work:
UCLA Radiology Services
757 Westwood Plz, Los Angeles, CA 90095
310-2678700 (phone) 310-2672059 (fax)
UCLA Medical GroupUCLA Medical Center MRI Research
300 Medical Plz, Los Angeles, CA 90095
310-2063098 (phone) 310-2061914 (fax)
Site
Education:
Medical School
Univ Coll of Galway, Nat'l Univ of Ireland, Fac of Med, Galway, Ireland
Graduated: 1978
Languages:
English
Description:
Dr. Finn graduated from the Univ Coll of Galway, Nat'l Univ of Ireland, Fac of Med, Galway, Ireland in 1978. He works in Los Angeles, CA and 1 other location and specializes in Diagnostic Radiology and Cardiothoracic Radiology. Dr. Finn is affiliated with Ronald Reagan UCLA Medical Center and Santa Monica UCLA Medical Center.
John Finn Photo 5

John Charles Finn

Specialties:
Otolaryngology
Facial Plastic Surgery
Otolaryngology/Facial Plastic Surgery
Plastic Surgery
Plastic Surgery Within the Head and Neck
Education:
Case Western Reserve University(1989)
John Finn Photo 6

John Joseph Finn

Specialties:
Family Medicine
Adult Medicine
General Practice
Education:
Creighton University (1965)
John Finn Photo 7

John Paul Finn, Los Angeles CA

Specialties:
Radiology
Diagnostic Radiology
Work:
UCLA Medical Center
10833 Le Conte Ave, Los Angeles, CA 90095Ronald Reagan Ucla Medical Center
757 Westwood Plz, Los Angeles, CA 90095Northwestern University
448 E Ontario St, Chicago, IL 60611
Education:
National University Of Ireland University College At Galway (1978)

License Records

John J Finn

Licenses:
License #: 1044 - Expired
Expiration Date: Jul 31, 1989
Type: Journeyman Electrician

John J Finn

Licenses:
License #: 1157-A - Expired
Expiration Date: Jul 31, 1989
Type: Master Electrician

Publications & IP owners

Us Patents

Method For Identifying Drug-Sensitizing Antisense Dna Fragments And Use Thereof

US Patent:
7910337, Mar 22, 2011
Filed:
Dec 8, 2006
Appl. No.:
11/636394
Inventors:
Robert Haselbeck - San Diego CA, US
Mark Hilgers - San Diego CA, US
Karen Shaw - Poway CA, US
Vickie Brown-Driver - Solana Beach CA, US
Kedar Gc - San Diego CA, US
John M. Finn - Encinitas CA, US
Mark Stidham - San Diego CA, US
Assignee:
Trius Therapeutics, Inc. - San Diego CA
International Classification:
C12P 19/34
C07H 21/04
C12N 15/63
C07K 16/00
US Classification:
435 912, 536 245, 4353201, 5303871
Abstract:
The invention provides a method for generating and selecting drug-sensitizing antisense DNA fragments. In one embodiment, the method includes identifying a gene of interest using knowledge of bacterial physiology, biochemistry, genetics, genomics, and other means. The method includes PCR amplification of a gene of interest using genomic DNA as a template; fragmentation of the DNA by sonication or other means; selecting DNA fragments no longer than 400 base pairs; ligating the DNA fragments into a suitable expression plasmid with a selectable marker; transforming the plasmids containing the DNA fragments into the organism from which the gene of interest originated; and selecting clones from transformed cells that show a phenotypic difference of the clone grown in the presence of the inducer relative to the phenotype in the absence of inducer.

Identification And Application Of Antibiotic Synergy

US Patent:
8021665, Sep 20, 2011
Filed:
Dec 8, 2006
Appl. No.:
11/636379
Inventors:
Vickie Brown-Driver - San Diego CA, US
Kedar GC - San Diego CA, US
John M. Finn - Encinitas CA, US
Robert Haselbeck - San Diego CA, US
Mark Hilgers - San Diego CA, US
Karen Shaw - Poway CA, US
Mark Stidham - San Diego CA, US
Assignee:
Trius Therapeutics, Inc. - San Diego CA
International Classification:
A61K 31/00
A61K 31/43
A61K 39/00
US Classification:
4241841, 514 1, 514198, 514199
Abstract:
The present invention provides a pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof, an antibacterially effective combination of a β-lactam antibiotic and an inhibitor of any bacterial peptidoglycan biosynthesis enzyme, especially GlmU, GlmU, MurA, MurB, MurC, MurD, MurE, MurF, MurG, MraY, and UppS. Further provided is a method of discovering synergists for antibiotics including: a) expressing in a cell an antisense nucleic acid against a nucleic acid encoding a gene product so as to reduce the activity or amount of the gene product in the cell, thereby producing a cell sensitized to an antibiotic; b) characterizing the sensitization of the cell to the antibiotic and selecting pairs of antibiotics and genes that result in antibiotic efficacy at one-fifth or less the concentration required in the absence of the antisense gene; c) screening for chemical compounds that inhibit the gene product corresponding to the selected synergistic gene; and d) selecting or creating chemical analogs that inhibit the gene product corresponding to the selected synergistic gene such that the inhibition occurs in the bacteria.

Identification And Application Of Antibiotic Synergy

US Patent:
8298543, Oct 30, 2012
Filed:
May 6, 2011
Appl. No.:
13/102856
Inventors:
Vickie Brown-Driver - Solana Beach CA, US
Kedar GC - San Diego CA, US
John M. Finn - Encinitas CA, US
Robert Haselbeck - San Diego CA, US
Mark Hilgers - San Diego CA, US
Karen Shaw - Poway CA, US
Mark Stidham - San Diego CA, US
Assignee:
Trius Therapeutics, Inc. - San Diego CA
International Classification:
A61K 31/00
A61K 31/43
A61K 39/00
US Classification:
4241841, 514 1, 514198, 514199
Abstract:
The present invention provides a pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof, an antibacterially effective combination of a β-lactam antibiotic and an inhibitor of any bacterial peptidoglycan biosynthesis enzyme, especially GlmU, GlmU, MurA, MurB, MurC, MurD, MurE, MurF, MurG, MraY, and UppS. Further provided is a method of discovering synergists for antibiotics including: a) expressing in a cell an antisense nucleic acid against a nucleic acid encoding a gene product so as to reduce the activity or amount of the gene product in the cell, thereby producing a cell sensitized to an antibiotic; b) characterizing the sensitization of the cell to the antibiotic and selecting pairs of antibiotics and genes that result in antibiotic efficacy at one-fifth or less the concentration required in the absence of the antisense gene; c) screening for chemical compounds that inhibit the gene product corresponding to the selected synergistic gene; and d) selecting or creating chemical analogs that inhibit the gene product corresponding to the selected synergistic gene such that the inhibition occurs in the bacteria.

Antimicrobial Compositions And Methods Of Use

US Patent:
2008019, Aug 14, 2008
Filed:
Feb 7, 2008
Appl. No.:
12/027950
Inventors:
Xiaoming Li - San Diego CA, US
John M. Finn - San Diego CA, US
Mark T. Hilgers - San Diego CA, US
Assignee:
TRIUS THERAPEUTICS - San Diego CA
International Classification:
A61K 31/551
C07D 403/12
C07D 403/14
A61K 31/541
A61K 31/506
A61K 31/53
A61P 31/04
A61K 31/5377
C07D 417/14
C07D 413/14
US Classification:
514218, 544321, 544295, 544296, 540575, 544 62, 544123, 544212, 5142282, 5142345, 51425219, 514272, 514245
Abstract:
The present invention is directed to compounds of formula I, pharmaceutical compositions comprising the compounds, and methods for making and using the inventive compounds.

Method For Identifying Drug-Sensitizing Antisense Dna Fragments And Use Thereof

US Patent:
2011014, Jun 16, 2011
Filed:
Feb 23, 2011
Appl. No.:
13/033128
Inventors:
Robert Haselbeck - San Diego CA, US
Mark Hilgers - San Diego CA, US
Karen Shaw - Poway CA, US
Vickie Brown-Driver - Solana Beach CA, US
Kedar GC - San Diego CA, US
John M. Finn - Encinitas CA, US
Mark Stidham - San Diego CA, US
International Classification:
C12Q 1/68
US Classification:
435 613, 435 615
Abstract:
The invention provides a method for generating and selecting drug-sensitizing antisense DNA fragments. In one embodiment, the method includes identifying a gene of interest using knowledge of bacterial physiology, biochemistry, genetics, genomics, and other means. The method includes PCR amplification of a gene of interest using genomic DNA as a template; fragmentation of the DNA by sonication or other means; selecting DNA fragments no longer than 400 base pairs; ligating the DNA fragments into a suitable expression plasmid with a selectable marker; transforming the plasmids containing the DNA fragments into the organism from which the gene of interest originated; and selecting clones from transformed cells that show a phenotypic difference of the clone grown in the presence of the inducer relative to the phenotype in the absence of inducer.

Dihydrofolate Reductase Inhibitors

US Patent:
2012013, May 31, 2012
Filed:
Jun 2, 2011
Appl. No.:
13/151683
Inventors:
Zhiyong Chen - San Diego CA, US
Christopher J. Creghton - San Diego CA, US
Mark Cunningham - San Diego CA, US
John Finn - San Diego CA, US
Mark Hilgers - San Diego CA, US
Michael Jung - Los Angeles CA, US
Lucy Aguirre Kohnen - Cambridge MA, US
Thanh Lam - San Diego CA, US
Xiaoming Li - San Diego CA, US
Mark Stidham - San Diego CA, US
Les Tari - San Diego CA, US
Michael Trzoss - San Diego CA, US
Junhu Zhang - San Diego CA, US
Assignee:
TRIUS THERAPEUTICS, INC. - San Diego CA
International Classification:
A61K 31/517
C07D 401/14
C07D 239/72
A61P 31/10
A61P 33/00
A61P 31/04
A61P 29/00
C12N 9/99
C07D 417/14
US Classification:
51426621, 435184, 51426623, 5142664, 544284, 544291
Abstract:
The present disclosure provides compounds of Formula I:or a pharmaceutically acceptable salt thereof, wherein R, Rand Z are as described herein. The disclosure also provides pharmaceutical compositions thereof; and methods for inhibiting DHFR activity; and methods for treating cell proliferative diseases, autoimmune disease, inflammatory disease or bacterial, fungal or parasitic infection by administering a compound of Formula I.

Tricyclic Gyrase Inhibitors

US Patent:
2012023, Sep 20, 2012
Filed:
Mar 14, 2012
Appl. No.:
13/496188
Inventors:
Daniel Bensen - Carlsbad CA, US
Zhiyong Chen - San Diego CA, US
John Finn - Encinitas CA, US
Thanh To Lam - San Diego CA, US
Suk Joong Lee - San Diego CA, US
Xiaoming Li - San Diego CA, US
Douglas W. Phillipson - Del Mar CA, US
Leslie William Tari - San Diego CA, US
Michael Trzoss - San Diego CA, US
Junhu Zhang - San Diego CA, US
Felice C. Lightstone - Fremont CA, US
Toan B. Nguyen - San Ramon CA, US
Sergio E. Wong - San Jose CA, US
Paul Aristoff - Dexter MI, US
Michael Jung - Los Angeles CA, US
Assignee:
TRIUS THERAPEUTICS, INC. - San Diego CA
International Classification:
C07D 487/04
C07D 471/10
C07D 487/08
C07D 471/08
C07D 487/10
C07D 491/048
C07D 491/056
C07D 487/14
C07D 471/14
C07D 471/04
C07D 498/04
US Classification:
540600, 544250, 544230, 544115, 544105, 544231, 544251
Abstract:
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors.Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.

Gyrase Inhibitors

US Patent:
2013007, Mar 28, 2013
Filed:
Sep 10, 2010
Appl. No.:
13/394985
Inventors:
Christopher J. Creighton - San Diego CA, US
Leslie William Tari - San Diego CA, US
Zhiyong Chen - San Diego CA, US
Mark Hilgers - San Diego CA, US
Thanh To Lam - San Diego CA, US
Xiaoming Li - San Diego CA, US
Michael Trzoss - San Diego CA, US
Junhu Zhang - San Diego CA, US
John Finn - San Diego CA, US
Daniel Bensen - Carlsbad CA, US
Assignee:
TRIUS THERAPEUTICS, INC. - San Diego CA
International Classification:
C07D 487/04
C07D 471/04
C07D 491/048
C07D 487/16
C07D 513/04
US Classification:
51421016, 544280, 5142651, 51425216, 5142342, 544117, 514249, 544265, 51426321, 514267, 544251, 51421021, 544250, 544279, 5142641, 51425202, 544238
Abstract:
Novel gyrase inhibitors and related compositions and methods are useful for impeding bacterial growth. Compounds of Formula (I), are disclosed: Formula (I), wherein Y is N or CH; Z is N or CR; Ris H, a substituted or unsubstituted hydrocarbyl residue (1-3C) containing 0-2 heteroatoms selected from O, S and N, or is an inorganic residue; L is O, S, NR, or CRR; Ris H or Calkyl; Rand Rare each independently H or Calkyl; Ris H, a hydrocarbyl residue (1-40C) containing 0-10 heteroatoms selected from O, S and N optionally substituted with an inorganic residue; Ris H, an inorganic residue, or a hydrocarbyl residue (1-30C) containing 0-12 heteroatoms selected from O, S and N and containing 0-10 inorganic residues, wherein Rand Rtogether may join to form a fused ring; and Ris selected from the group consisting of H, Calkyl, Calkenyl, Calkynyl, halo Calkyl, halo Calkenyl, halo Calkynyl, Chydroxyalkyl, Calkyl chloride, Calkenyl chloride, and Calkynyl chloride; or a pharmaceutically-acceptable salt, ester, or prodrug thereof.

Isbn (Books And Publications)

Constitutions In Crisis: Political Violence And The Rule Of Law

Author:
John E. Finn
ISBN #:
0195057384

American Constitutional Law: Essays, Cases, And Comparative Notes

Author:
John E. Finn
ISBN #:
0314127453

Constitutional Law

Author:
John E. Finn
ISBN #:
0534539378

American Constitutional Law: Cases, Essays, And Comparative Notes

Author:
John E. Finn
ISBN #:
0534539386

American Constitutional Law: Essays, Cases, And Comparative Notes

Author:
John E. Finn
ISBN #:
0742526879

American Constitutional Law: Essays, Cases, And Comparative Notes

Author:
John E. Finn
ISBN #:
0742526887

American Constitutional Law: Liberty, Community, And The Bill Of Rights

Author:
John E. Finn
ISBN #:
0742526933

Flashback: A Journey In Time

Author:
John Michael Finn
ISBN #:
0759612919

Possible Relatives

David E Finn  Dale M Finn  Deborah A Finn  Dana L Finn  Debra Finn  Daniel M Finn  Declan P Finn  John M Johnson  John Stamps  John R Stan 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.